Pipeline - United Immunity

Pipeline

United Immunity’s pipeline has developed innovative therapies for cancer, with a focus on treatment-resistant solid tumors and fibrotic diseases, including metabolic dysfunction-associated steatohepatitis (MASH) and idiopathic pulmonary fibrosis (IPF).

Discovery

Lead

Preclinical

Ph 1

Ph 2

Ph 3

UI-102

Mode Of Action

Cold tumor to hot conversion

We want to provide you with the most important information and services in the best possible way. In order to do this, we need your consent to use the web analysis tool »Matomo« to create and evaluate an anonymous analysis of your visit for statistical purposes. You can change your consent at any time on the data protection page, otherwise it will remain valid for twelve months.